Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Qiagen N.V. before investing.

In this article, we go over a few key elements for understanding Qiagen N.V.’s stock price such as:

• Qiagen N.V.’s current stock price and volume
• Why Qiagen N.V.’s stock price changed recently
• Upgrades and downgrades for QGEN from analysts
• QGEN’s stock price momentum as measured by its relative strength

About Qiagen N.V. (QGEN)

Before we jump into Qiagen N.V.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Want to learn more about Qiagen N.V.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Qiagen N.V..

Qiagen N.V.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Qiagen N.V.’s stock price was $41.400.

Qiagen N.V. is down 0.12% from its previous closing price of $41.450.

During the last market session, Qiagen N.V.’s stock traded between $40.960 and $41.570. Currently, there are approximately 207.01 million shares outstanding for Qiagen N.V..

Qiagen N.V.’s price-earnings (P/E) ratio is currently at 21.3, which is low compared to the Life Sciences Tools & Services industry median of 43.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Qiagen N.V. Stock Price History

Qiagen N.V.’s (QGEN) price is currently up 5.88% so far this month.

During the month of July, Qiagen N.V.’s stock price has reached a high of $44.030 and a low of $37.690.

Over the last year, Qiagen N.V. has hit prices as high as $57.815 and as low as $32.530. Year to date, Qiagen N.V.’s stock is down 12.54%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Qiagen N.V. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded Qiagen N.V.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Qiagen N.V.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Qiagen N.V.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Qiagen N.V.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Qiagen N.V. (QGEN) by visiting AAII Stock Evaluator.

Relative Price Strength of Qiagen N.V.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Qiagen N.V. has a weighted four-quarter relative price strength of -2.04%, which translates to a Momentum Score of 45 and is considered to be Average.

Want to learn more about how Qiagen N.V. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Qiagen N.V. Stock Price: Bottom Line

As of July 31, 2026, Qiagen N.V.’s stock price is $41.400, which is down 0.12% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Qiagen N.V. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.